Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: BIS Research | PRODUCT CODE: 1442612

Cover Image

PUBLISHER: BIS Research | PRODUCT CODE: 1442612

Nucleic Acid Sample Preparation Market - A Global and Regional Analysis: Focus on Technology, Application, Product, End User, and Country - Analysis and Forecast, 2023-2033

PUBLISHED:
PAGES: 265 Pages
DELIVERY TIME: 1-5 business days
SELECT AN OPTION
PDF and Excel (1-3 User License)
USD 4950
PDF and Excel (Global License)
USD 7650

Add to Cart

The Global Nucleic Acid Sample Preparation Market Expected to Reach $5,615.9 Million by 2033

Introduction to Nucleic Acid Sample Preparation Market

The global nucleic acid sample preparation market is projected to reach $5,615.9 million by 2033 from $2,922.8 million in 2023, growing at a CAGR of 6.75% during the forecast period 2023-2033. The key factors driving the growth of the global nucleic acid sample preparation market include the growth in the number of genetic tests globally and an increase in demand for reliable next-generation sequencing (NGS) platforms in clinical laboratories.

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$2,922.8 Million
2033 Forecast$5,615.9 Million
CAGR6.75%

Impact Analysis:

The nucleic acid sample preparation market has made an impact in the following ways:

Emergence of Advanced Stabilization Products: The rapid growth of genomic research has resulted in an increasing need for the storage of biologic samples, including DNA and RNA. Stabilization products enable researchers to transport and store biological samples for long periods with complete and rapid sample recovery at affordable costs. These products are used to retain biological materials at room temperature without degradation. These stabilization products ensure that the nucleic material, which has been carefully purified, remains safe and ready for further downstream applications, such as ensuring accurate gene expression analysis through qPCR or QRT-PCR. Research studies suggest that cell lysates created using lysis and stabilization buffers observed no shift in Ct value versus fresh samples, indicating that the nucleic acid was stable and intact while stored in these stabilization solutions.

Regulated vs. Multimodal Analysis: In order to cross-examine biological samples for changes in DNA and RNA efficiently, there have been considerable advances in NGS chemistries, platforms, and bioinformatics pipelines. Currently, the regulated approach requires the use of two separate workflows for library preparation from separate DNA and RNA isolates. The regulated analysis approach presents certain limitations, such as the large amounts of sample required for generating sufficient nucleic acid for multiple workflows, inefficient use of resources, and long turn-around times.

Nucleic Acid Sample Preparation Market Segmentation:

Segmentation 1: by Product

  • Consumables
  • Instruments

Consumables Segment to Continue Dominating the Nucleic Acid Sample Preparation Market (by Product)

Based on product, the nucleic acid sample preparation market has been led by consumables, which held a 67.83% share in 2022.

Segmentation 2: Consumables Market by Type

  • Kits
  • Reagents

Kits Segment to Continue Dominating the Nucleic Acid Sample Preparation Consumables Market by Type

Based on consumables market by type, the nucleic acid sample preparation market has been led by Kits, which held a 87.65% share in 2022.

Segmentation 3: Kits by Type

  • DNA/RNA Sample Isolation/Extraxtion/Purification
  • DNA/RNA Clean-Up and Concentration
  • DNA and RNA Quantification

DNA/RNA Sample Isolation/Extraxtion/Purification Segment to Continue Dominating the Nucleic Acid Sample Preparation Consumables Market Kits by Type

Based on nucleic acid sample preparation consumables market Kits by Type, the nucleic acid sample preparation market has been led by DNA/RNA Sample Isolation/Extraxtion/Purification, which held an 83.93% share in 2022.

Segmentation 4: Consumables Market by Analyte

  • DNA
  • RNA

DNA Segment to Continue Dominating the Nucleic Acid Sample Preparation Market (Consumables Market by Analyte)

Based on consumables market by analyte, the nucleic acid sample preparation market has been led by DNA, which held a 64.57% share in 2022.

Segmentation 5: by Technology

  • Consumable-Based Technology
    • Silica-Based
    • Magnetic Particle Technology
    • Other Technologies
  • Instrument-Based Technology
    • Automated Spin Column-Based
    • Magnetic Bead-Based
    • Automated Liquid Handling

Silica-Based Segment to Continue Dominating the Nucleic Acid Sample Preparation Consumable Market (by Consumable-Based Technology)

Based on consumable-based technology, the nucleic acid sample preparation consumable market has been led by silica-based technology, which held a 48.58% share in 2022.

Magnetic Bead-Based Segment to Continue Dominating the Nucleic Acid Sample Preparation Instrument Market (by Instrument-Based Technology)

Based on instrument-based technology, the nucleic acid sample preparation instrument market has been led by magnetic bead-based, which held a 58.72% share in 2022.

Segmentation 6: by Application

  • PCR
  • qPCR
  • NGS
  • Cloning
  • Microarray
  • Blotting Techniques
  • Other Applications

qPCR Segment to Hold its Dominance in the Nucleic Acid Sample Preparation Market (by Application)

Based on application, the nucleic acid sample preparation market has been led by qPCR, which held a 31.87% share in 2022.

Segmentation 7: by End User

  • Academic Research Institutes and Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Clinical Diagnostic Centers
  • Applied Testing (Forensic, Biobanks)

Academic Research Institutes and Laboratories Segment to Continue its Dominance in the Nucleic Acid Sample Preparation Market (by End User)

Based on end user, the nucleic acid sample preparation market has been led by academic research institutes and laboratories, which held a 45.95% share in 2022.

Segmentation 8: by Region

  • North America - U.S., Canada
  • Europe, Middle East and Africa (EMEA)
  • Asia-Pacific - China, Japan, and Rest-of-Asia-Pacific
  • Latin America (LATAM)

China dominated the Asia-Pacific nucleic acid sample preparation market in 2022. China has maintained itself as an attractive market for life sciences solution providers capable of tapping the strong demand for nucleic acid extraction products. Several companies, including Qiagen, Thermo Fisher Scientific, BioTeke, Promega, F. Hoffmann-La Roche AG, and Takara Bio, are the leading suppliers of nucleic acid extraction consumables in the country.

The Chinese government recognizes the potential of nucleic acid sample preparation and is actively promoting its development and manufacturing.

Recent Developments in the Nucleic Acid Sample Preparation Market

  • In November 2023, Qiagen N.V. introduced two groundbreaking additions to its sample technologies portfolio, i.e., the TissueLyser III that facilitates high-throughput disruption of diverse biological samples and the RNeasy PowerMax Soil Pro Kit that isolates high-purity RNA from challenging soil samples using advanced Inhibitor Removal Technology.
  • In July 2023, Qiagen announced the launch of the QIAseq Normalizer Kits that give researchers a fast, convenient, and cost-effective method to pool different DNA libraries for best-quality results from next-generation sequencing (NGS) runs.
  • In October 2023, PerkinElmer introduced the CHEF Magnetic Bead Cleanup System, providing automated nucleic acid purification through advanced magnetic bead technology. This novel system would help automate the nucleic acid purification process efficiently.
  • In May 2023, PerkinElmer (Revvity, Inc.) rebranded its diagnostics and life sciences business as Revvity. This strategic move marked a new identity and focus for the company's ventures in these sectors.
  • In October 2022, PerkinElmer (Revvity, Inc.) and Element Biosciences, Inc. partnered to unveil innovative workflow solutions aimed at reducing the time and effort needed for the genomic analysis of samples, specifically leveraging the AVITI System, which is an emerging genomic sequencing platform.
  • In December 2023, Thermo Fisher Scientific Inc., the world leader in serving science, announced the launch of the Thermo Scientific KingFisher Apex Dx, an automated nucleic acid purification instrument, and Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit for the isolation and purification of viral and bacterial pathogens from respiratory biological specimens.
  • In November 2023, Thermo Fisher Scientific unveiled the Ion Torrent Genexus System, providing high-throughput sequencing capabilities for a diverse range of NGS applications. This innovative system would cater to the demands of high-throughput NGS applications.
  • In August 2023, Zymo Research unveiled the Quick-DNA Microprep Kit, providing swift and high-purity genomic DNA isolation from diverse sample types. This newly introduced kit would address the need for rapid and efficient genomic DNA isolation.

Demand - Drivers and Limitations

Market Demand Drivers:

Growing Number of Genetic Tests: The growing adoption of genetic tests has ushered in a transformative era in healthcare, research, and personalized medicine. These tests, which encompass a wide range of applications, from diagnosing genetic disorders to uncovering ancestry information, have become increasingly popular among individuals and healthcare providers alike. As this adoption curve continues to climb, it will bring a significant rise and consistency in demand for nucleic acid sample preparation methods.

Increasing Demand for Reliable Next-Generation Sequencing (NGS) Platforms in Clinical Laboratories: The expanding utilization of next-generation sequencing (NGS) platforms within clinical laboratories is driving a substantial upswing in the demand for DNA/RNA sample preparation procedures. This increased demand can be primarily attributed to the critical role that NGS plays in advancing clinical diagnostics and personalized medicine. Moreover, NGS technologies have emerged as a crucial tool for revolutionizing the understanding of genomics and the molecular characteristics of various biological samples. It is gaining rapid acceptance in clinical practice due to its high throughput capabilities, allowing simultaneous analysis of numerous genes at both germline and somatic levels while using minimal starting material.

Increasing Prevalence of Infectious Diseases and Cancer Cases: The increasing prevalence of infectious diseases and cancer cases is driving a significant surge in the demand for nucleic acid sample preparation consumables and instruments. This growing demand is primarily due to the pivotal role that genetic analysis plays in the diagnosis, treatment, and monitoring of infectious diseases.

For instance, according to the International Agency for Research on Cancer (IARC), the global cancer burden was estimated at 24.3 million new cases in 2020, with a worldwide five-year prevalence estimated at 50.6 million.

Market Restraints:

High Cost of Automated Instruments: Nucleic acid isolation is one of the crucial steps in performing DNA and RNA extraction. Automation has been incorporated into nucleic acid isolation to ease the overall process of extraction and purification by reducing the time and errors associated with it. Although the price tag for various processes in which DNA extraction is applicable has been declining over the course of time, it has not reached a point where wide adoption in developing markets across the globe can be achieved. This high price tag is restricting the adoption of high-tech nucleic acid isolation platforms by hospitals/clinics, forensic centers, and academic/research institutes, among others, which are present in emerging markets all around the globe. Moreover, high capital investment is required to establish automated technology for sample preparation of genetic materials.

Rigid Regulatory Standards: Automated nucleic acid isolation has enhanced the overall nucleic acid sample preparation process by saving time, increasing throughput, and reducing human errors. As per the Food and Drug Administration (FDA), all test elements, such as software, reagents, consumables, and instrumentation, which are used in next-generation sequencing, should be well documented and specified. Additionally, it also states that the materials used for library preparation and laboratory equipment, such as automated liquid handlers, should also be well documented and specified. Moreover, with respect to the input and sample preparation, storage, processing, handling, and preservation should be well established and documented. There are some regulatory standards that are set by government regulatory bodies and need to be strictly followed while using automated sample preparation and nucleic acid isolation systems.

Market Opportunities:

Development and Utilization of More Biobanks in the Healthcare Segment: The healthcare industry is undergoing a transformative shift driven by advances in genomics, personalized medicine, and targeted therapies. The center of this evolution is the growing demand for DNA and RNA isolation, which is vital for understanding genetic underpinnings, diagnosing diseases, and developing tailored treatments. In this context, the development and utilization of more biobanks are indispensable, as they serve as the lifeblood of the nucleic acid sample preparation market, propelling healthcare forward. They provide a diverse range of genetic materials, enabling scientists to delve deep into the intricacies of human genetics. As more biobanks are established, the availability of genetic samples is amplified, thereby facilitating a deeper understanding of genetic variations and their impact on health.

Technological Advancements in DNA/RNA Sample Preparation Processes: Technological advancements in DNA/RNA sample preparation processes, including spin-column and automation in magnetic beads methods, have revolutionized molecular biology and genetics research. These innovations have made nucleic acid sample preparation more efficient, reliable, and scalable. For instance, technological advancements have led to the development of high-quality spin columns and membranes. These materials are designed to efficiently capture nucleic acids while removing impurities, ensuring pure and intact DNA/RNA samples.

How can this report add value to the Organization ?

Product/Innovation Strategy: The global nucleic acid sample preparation market has been extensively segmented based on various categories, such as product, technology, application, end user, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: Product launches/product approvals accounted for the maximum number of key developments, i.e., nearly 66.04% of the total developments in the global nucleic acid sample preparation market were between January 2018 and December 2023.

Competitive Strategy: The global nucleic acid sample preparation market has numerous established players with product and service portfolios. Key players in the global nucleic acid sample preparation market analyzed and profiled in the study involve established players offering products and services of nucleic acid sample preparation.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • Detailed secondary research was performed to ensure maximum coverage of manufacturers/suppliers operational in a country.
  • Exact revenue information, up to a certain extent, was extracted for each company from secondary sources and databases. The revenues specific to the product, technology, application, end user, and region were then estimated for each market player based on fact-based proxy indicators as well as primary inputs.
  • The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of nucleic acid sample preparation.
  • The market contribution of the nucleic acid sample preparation anticipated to be launched in the future has been calculated based on historical analysis. This analysis has been supported by proxy factors such as the innovation scale of the companies, the status of funding, collaborations, customer base, and patent scenario.
  • The scope of availability of nucleic acid sample preparation in a particular region has been assessed based on a comprehensive analysis of companies' prospects, regional end-user perception, and other factors impacting the launch of nucleic acid sample preparation in that region.
  • The base year considered for the calculation of the nucleic acid sample preparation market size is 2022. A historical year analysis has been done for the period FY2020-FY2021. The nucleic acid sample preparation market size has been estimated for FY2022 and projected for the period FY2023-FY2033.
  • Revenues of the companies have been referenced from their annual reports for FY2020- FY2022. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, product approval status, market collaborations, and operational history.
  • Regional distribution of the nucleic acid sample preparation market revenue has been estimated based on the companies in each region and the adoption rate of nucleic acid sample preparation. All the numbers have been adjusted to a single digit after the decimal for better presentation in the report. However, the real figures have been utilized for compound annual growth rate (CAGR) estimation. The CAGR has been calculated for the period 2023-2033.
  • The nucleic acid sample preparation market has been mapped based on the available nucleic acid sample preparation. All the key companies with significant offerings in this field have been considered and profiled in this report.
  • Nucleic acid sample preparation market strategies and developments of key players have been considered for the calculation of the potential of the nucleic acid sample preparation market in the forecast period.

Primary Research:

The primary sources involve industry experts in the nucleic acid sample preparation market, including the market players offering nucleic acid sample preparation solutions. Resources such as CXOs, vice presidents, product managers, directors, territory managers, and business development have been interviewed to obtain and verify both qualitative and quantitative aspects of nucleic acid sample preparation market research study.

The key data points taken from the primary sources include:

  • Validation and triangulation of all the numbers and graphs
  • Validation of the report's segmentation and key qualitative findings for nucleic acid sample preparation
  • Understanding the competitive landscape and business model
  • Current and proposed production values of a product by market players
  • Validation of the numbers of the different segments of the market in focus
  • Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • European Medicines Agency (EMA), American Chemical Society (ACS), Frontiers, World Health Organization (WHO), National Institute of Health (NIH), China Food and Drug Administration (CFDA), U.S. Food and Drug Administration (FDA), National Centre for Biotechnology Information (NCBI), and others
  • Annual reports, SEC filings, and investor presentations of the leading nucleic acid sample preparation market players
  • Company websites and detailed study of their portfolios
  • Gold standard magazines, journals, whitepapers, press releases, and news articles
  • Databases

The key data points taken from the secondary sources include:

  • Segmentation and percentage share estimates
  • Companies' and countries' understanding and data for nucleic acid sample preparation market value estimation.
  • Key industry/market trends of nucleic acid sample preparation market
  • Developments among top players of nucleic acid sample preparation market
  • Qualitative insights into various aspects of the nucleic acid sample preparation market, key trends, and emerging areas of innovation
  • Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, type portfolio, and market penetration.

Some prominent names in the global nucleic acid sample preparation market include:

  • Agilent Technologies, Inc.
  • Autogen, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Merck KGaA
  • Macherey-Nagel GmbH & Co KG
  • New England Biolabs, Inc.
  • Norgen Biotek Corp.
  • Omega Bio-tek, Inc.
  • Revvity, Inc. (PerkinElmer, Inc.)
  • Promega Corporation
  • QIAGEN N.V.
  • Sage Science, Inc.
  • Tecan Group
  • Thermo Fisher Scientific Inc.
  • Zymo Research
Product Code: BHP1345SB

Table of Contents

Executive Summary

Scope of the Study

1 Markets

  • 1.1 Definitions
    • 1.1.1 Definition by Products
      • 1.1.1.1 Instruments
      • 1.1.1.2 Column-Based Instruments
      • 1.1.1.3 Bead-Based Instruments
      • 1.1.1.4 Low-Throughput Instruments
      • 1.1.1.5 Medium-Throughput Instruments
      • 1.1.1.6 High-Throughput Instruments
      • 1.1.1.7 Kits
      • 1.1.1.8 Reagents
  • 1.2 Nucleic Acid Sample Preparation Automation Applications
    • 1.2.1 Genomic/Plasmid DNA Extraction
    • 1.2.2 Cell-Free DNA (cfDNA) Extraction
    • 1.2.3 Viral RNA Extraction
    • 1.2.4 Cell-Free RNA Extraction
  • 1.3 Market Attractiveness: Macro and Micro Factor Analysis
  • 1.4 Market Dynamics
    • 1.4.1 Impact Analysis
    • 1.4.2 Market Drivers
      • 1.4.2.1 Growing Number of Genetic Tests
      • 1.4.2.2 Increasing Demand for Reliable Next-Generation Sequencing (NGS) Platforms in Clinical Laboratories
      • 1.4.2.3 Increasing Prevalence of Infectious Diseases and Cancer Cases
      • 1.4.2.4 Rise in the Field of Microbial Sequencing
      • 1.4.2.5 Increase in Awareness and Acceptance of Personalized Medicines on a Global Level
      • 1.4.2.6 Decreasing Cost of Sequencing
    • 1.4.3 Market Restraints
      • 1.4.3.1 Genomic Data Protection
      • 1.4.3.2 High Cost of Automated Instruments
      • 1.4.3.3 Rigid Regulatory Standards
    • 1.4.4 Market Opportunities
      • 1.4.4.1 Development and Utilization of More Biobanks in Healthcare Segment
      • 1.4.4.2 Technological Advancements in DNA/RNA Sample Preparation Processes
      • 1.4.4.3 Growth in Emerging Nations
      • 1.4.4.4 Massive Scope for Adoption of NGS-based Genetic Tests in Emerging Markets

2 Nucleic Acid Sample Preparation Market: Industry Insights

  • 2.1 Key Developments
    • 2.1.1 Product Launches and Approvals
    • 2.1.2 Collaborations and Agreements
    • 2.1.3 Acquisitions
    • 2.1.4 Business Expansions
  • 2.2 Industry Trends
    • 2.2.1 Emergence of Advanced Stabilization Products
    • 2.2.2 Regulated vs. Multimodal Analysis
    • 2.2.3 Exploring New Applications
    • 2.2.4 Other Key Trends

3 Nucleic Acid Sample Preparation Market: End User and Pricing Analysis

  • 3.1 Satisfaction Level of Different Instruments (by Brand)
  • 3.2 Pricing Analysis of Preferred Instruments
  • 3.3 Pricing Analysis - Accessories and Components
  • 3.4 Pricing Analysis - Consumables

4 Nucleic Acid Sample Preparation Market (by Product), $Million, 2022-2033

  • 4.1 Introduction
  • 4.2 Consumables
    • 4.2.1 Kits
    • 4.2.2 Reagents
  • 4.3 Instruments

5 Nucleic Acid Sample Preparation Kits Market, $Million, 2022-2033

  • 5.1 By Workflow
    • 5.1.1 Sample Isolation/Extraction/Purification
    • 5.1.2 DNA/RNA Clean-Up and Concentration
    • 5.1.3 DNA and RNA Quantification
  • 5.2 By Analyte
    • 5.2.1 DNA
    • 5.2.2 RNA

6 DNA Sample Preparation Kits Market, (by Source Type) $Million, 2022-2033

  • 6.1 Cell-Free
    • 6.1.1 By Sample
      • 6.1.1.1 Blood
      • 6.1.1.2 Serum/Plasma
      • 6.1.1.3 Other Sources
    • 6.1.2 By Application
      • 6.1.2.1 Parental and Hereditary Testing
      • 6.1.2.2 Tumor Testing
      • 6.1.2.3 Transplantation
  • 6.2 Genomic
    • 6.2.1 Blood
    • 6.2.2 Body Fluids
    • 6.2.3 Buccal
    • 6.2.4 Cell/Cultured Cell
    • 6.2.5 FFPE
    • 6.2.6 Forensic
    • 6.2.7 Plant
    • 6.2.8 Saliva/Swab
    • 6.2.9 Serum/Plasma
    • 6.2.10 Tissue
    • 6.2.11 Stool, Urine, and Other Samples
  • 6.3 Microbe
    • 6.3.1 Bacterial
    • 6.3.2 Fungus
    • 6.3.3 Yeast
    • 6.3.4 Other Sources
  • 6.4 Plasmid
    • 6.4.1 GigaPrep
    • 6.4.2 MaxiPrep
    • 6.4.3 MegaPrep
    • 6.4.4 MidiPrep
    • 6.4.5 MiniPrep
  • 6.5 Viral

7 RNA Sample Preparation Kits Market (by Source Type) $Million, 2022-2033

  • 7.1 Genomic RNA
    • 7.1.1 Blood
    • 7.1.2 Body Fluids
    • 7.1.3 Cell/Cultured Cell
    • 7.1.4 FFPE
    • 7.1.5 Plant
    • 7.1.6 Saliva/Swab
    • 7.1.7 Serum/Plasma
    • 7.1.8 Tissue
    • 7.1.9 Urine
    • 7.1.10 Others
  • 7.2 Microbial RNA
    • 7.2.1 Bacteria
    • 7.2.2 Yeast
    • 7.2.3 Fungus
    • 7.2.4 Others
  • 7.3 Viral RNA
  • 7.4 Cell-Free RNA
    • 7.4.1 Serum/Plasma
    • 7.4.2 Others

8 Nucleic Acid Sample Preparation Consumables Market (by Technology), $Million, 2022-2033

  • 8.1 Silica-Based
  • 8.2 Magnetic Particle Technology
  • 8.3 Other Technologies

9 Nucleic Acid Sample Preparation Consumables Market (by Downstream Applications), $Million, 2022-2033

  • 9.1 PCR
  • 9.2 qPCR
  • 9.3 NGS
  • 9.4 Cloning
  • 9.5 Microarray
  • 9.6 Blotting Techniques
  • 9.7 Other Applications

10 Nucleic Acid Sample Preparation Consumables Market (by End User), $Million, 2022-2033

  • 10.1 Introduction
  • 10.2 Academic Research Institutes and Laboratories
  • 10.3 Pharmaceutical and Biotechnology Companies
  • 10.4 Contract Research Organizations
  • 10.5 Applied Testing
  • 10.6 Clinical Diagnostic Centers

11 Nucleic Acid Sample Preparation Consumables Market (by Region)

  • 11.1 North America
    • 11.1.1 U.S.
    • 11.1.2 Canada
  • 11.2 Europe, Middle East & Africa (EMEA)
  • 11.3 Latin America (LATAM)
  • 11.4 Asia-Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 Rest-of-APAC

12 Nucleic Acid Sample Preparation Instrument Market

  • 12.1 Introduction
  • 12.2 Nucleic Acid Sample Preparation Instrument Market (by Workflow)
    • 12.2.1 Isolation/Extraction/Purification
    • 12.2.2 Quality Control/Quantification
  • 12.3 Nucleic Acid Sample Preparation Instrument Market (by Technology)
    • 12.3.1 Automated Spin Column-Based Instruments
    • 12.3.2 Magnetic Bead-based Instruments
    • 12.3.3 Automated Liquid Handling Instruments
  • 12.4 Nucleic Acid Sample Preparation Instrument Market (by Throughput)
    • 12.4.1 Low Throughput Instruments
    • 12.4.2 Medium Throughput Instruments
    • 12.4.3 High Throughput Instruments
  • 12.5 Quality Control/Quantification Instruments (by Technology)
    • 12.5.1 Spectrophotometer
    • 12.5.2 Fluorometers
    • 12.5.3 Others
  • 12.6 Nucleic Acid Sample Preparation Instrument Market (by End User)
    • 12.6.1 Academic Research Institutes
    • 12.6.2 Pharmaceutical and Biotechnology Companies
    • 12.6.3 Clinical Diagnostic Centers
    • 12.6.4 Applied Testing (Biobanks, Forensic and Veterinary Laboratories)
    • 12.6.5 Contract Research Organizations
  • 12.7 Nucleic Acid Sample Preparation Instrument Market (by Region)
    • 12.7.1 North America
      • 12.7.1.1 U.S.
      • 12.7.1.2 Canada
    • 12.7.2 Europe, Middle East, and Africa
    • 12.7.3 Asia-Pacific
      • 12.7.3.1 China
      • 12.7.3.2 Japan
      • 12.7.3.3 Rest-of-APAC
    • 12.7.4 Latin America

13 Nucleic Acid Sample Preparation Market Competitive Landscape

  • 13.1 Market Share Analysis

14 Company Profiles

  • 14.1 Agilent Technologies, Inc.
    • 14.1.1 Company Overview
    • 14.1.2 Role of Agilent Technologies, Inc. in the Global Nucleic Acid Sample Preparation Market
    • 14.1.3 Financials
    • 14.1.4 Analyst Perspective
  • 14.2 AutoGen, Inc.
    • 14.2.1 Company Overview
    • 14.2.2 Role of Autogen, Inc. in the Global Nucleic Acid Sample Preparation Market
    • 14.2.3 Analyst Perspective
  • 14.3 Bio-Rad Laboratories, Inc.
    • 14.3.1 Company Overview
    • 14.3.2 Role of Bio-Rad Laboratories, Inc. in the Global Nucleic Acid Sample Preparation Market
    • 14.3.3 Financials
    • 14.3.4 Analyst Perspective
  • 14.4 F. Hoffmann-La Roche AG
    • 14.4.1 Company Overview
    • 14.4.2 Role of F. Hoffmann-La Roche AG in the Global Nucleic Acid Sample Preparation Market
    • 14.4.3 Financials
    • 14.4.4 Analyst Perspective
  • 14.5 Merck KGaA
    • 14.5.1 Company Overview
    • 14.5.2 Role of Merck KGaA in the Global Nucleic Acid Sample Preparation Market
    • 14.5.3 Financials
    • 14.5.4 Analyst Perspective
  • 14.6 Macherey-Nagel GmbH & Co KG
    • 14.6.1 Company Overview
    • 14.6.2 Role of Macherey-Nagel GmbH & Co KG in the Global Nucleic Acid Sample Preparation Market
    • 14.6.3 Analyst Perspective
  • 14.7 New England Biolabs, Inc
    • 14.7.1 Company Overview
    • 14.7.2 Role of New England Biolabs, Inc. in the Global Nucleic Acid Sample Preparation Market
    • 14.7.3 Analyst Perspective
  • 14.8 Norgen Biotek Corp.
    • 14.8.1 Company Overview
    • 14.8.2 Role of Norgen Biotek Corp. in the Global Nucleic Acid Sample Preparation Market
    • 14.8.3 Analyst Perspective
  • 14.9 Omega Bio-tek, Inc.
    • 14.9.1 Company Overview
    • 14.9.2 Role of Omega Bio-tek, Inc., in the Global Nucleic Acid Sample Preparation Market
    • 14.9.3 Analyst Perspective
  • 14.1 Revvity, Inc. (PerkinElmer, Inc.)
    • 14.10.1 Company Overview
    • 14.10.2 Role of Revvity, Inc. (PerkinElmer, Inc.) in the Nucleic Acid Sample Preparation Market
    • 14.10.3 Financials
    • 14.10.4 Analyst Perspective
  • 14.11 Promega Corporation
    • 14.11.1 Company Overview
    • 14.11.2 Role of Promega Corporation in the Global Nucleic Acid Sample Preparation Market
    • 14.11.3 Analyst Perspective
  • 14.12 QIAGEN N.V.
    • 14.12.1 Company Overview
    • 14.12.2 Role of QIAGEN N.V. plc in the Global Nucleic Acid Sample Preparation Market
    • 14.12.3 Financials
    • 14.12.4 Analyst Perspective
  • 14.13 Sage Science, Inc.
    • 14.13.1 Company Overview
    • 14.13.2 Role of Sage Science, Inc. in the Global Nucleic Acid Sample Preparation Market
    • 14.13.3 Analyst Perspective
  • 14.14 Tecan Group
    • 14.14.1 Company Overview
    • 14.14.2 Role of Tecan Group in the Global Nucleic Acid Sample Preparation Market
    • 14.14.3 Financials
    • 14.14.4 Analyst Perspective
  • 14.15 Thermo Fisher Scientific Inc.
    • 14.15.1 Company Overview
    • 14.15.2 Role of Thermo Fisher Scientific in the Global Nucleic Acid Sample Preparation Market
    • 14.15.3 Financials
    • 14.15.4 Analyst Perspective
  • 14.16 Zymo Research
    • 14.16.1 Company Overview
    • 14.16.2 Role of Zymo Research in the Global Nucleic Acid Sample Preparation Market
    • 14.16.3 Analyst Perspective

15 Research Methodology

  • 15.1 Global Nucleic Acid Sample Preparation Market: Research Methodology
  • 15.2 Primary Data Sources
  • 15.3 Secondary Data Sources
  • 15.4 Market Estimation Model
Product Code: BHP1345SB

List of Figures

  • Figure 1: Nucleic Acid Sample Preparation Market, (by Product), $Million, 2022 vs. 2033
  • Figure 2: Nucleic Acid Sample Preparation Consumables Market, (by Type), $Million, 2022 vs. 2033
  • Figure 3: Nucleic Acid Sample Preparation Consumables (Kits) Market, (by Technology), $Million, 2022 vs. 2033
  • Figure 4: Nucleic Acid Sample Preparation Consumables Market, (by End User), $Million, 2022 vs. 2033
  • Figure 5: Global Nucleic Acid Sample Preparation Consumables Market Snapshot, (by Region) 2022 and 2033
  • Figure 6: Nucleic Acid Sample Preparation Instrument Market, (by Throughput), $Million, 2022 vs. 2033
  • Figure 7: Global Nucleic Acid Sample Preparation Instrument Market Snapshot, (by Region)
  • Figure 8: Global Nucleic Acid Sample Preparation Market Segmentation
  • Figure 9: Market Attractiveness Based on Key Characteristics
  • Figure 10: Global Cancer Incidence, 2017-2021
  • Figure 11: Decreasing Cost and Increasing Output (TB) of Genome Sequencing (2009-2025)
  • Figure 12: Cost per Genome, 2011-2022
  • Figure 13: Share of Key Developments and Strategies
  • Figure 14: Nucleic Acid Sample Preparation Customer Preference (by Major Brand), N=20
  • Figure 15: Nucleic Acid Sample Preparation Customer Satisfaction Level (5 Being the Highest) (by Brand) (N=20)
  • Figure 16: Nucleic Acid Sample Preparation Market (by Product), $Million, 2022 and 2033
  • Figure 17: Nucleic Acid Sample Preparation Consumables Market, $Million, 2022-2033
  • Figure 18: Nucleic Acid Sample Preparation Kits Market, $Million, 2022-2033
  • Figure 19: Nucleic Acid Sample Preparation Reagents Market, $Million, 2022-2033
  • Figure 20: Nucleic Acid Sample Preparation Instrument Market, $Million, 2022-2033
  • Figure 21: Nucleic Acid Sample Preparation Kits Market (by Workflow), $Million, 2022 and 2033
  • Figure 22: Sample Isolation/Extraction/Purification Kits Market, $Million, 2022-2033
  • Figure 23: DNA/RNA Clean-Up and Concentration Kits Market, $Million, 2022-2033
  • Figure 24: DNA and RNA Quantification Kits Market, $Million, 2022-2033
  • Figure 25: Nucleic Acid Sample Preparation Kits Market (by Analyte), $Million, 2022 and 2033
  • Figure 26: DNA Kits Market, $Million, 2022-2033
  • Figure 27: Market Share for DNA Kits Market, $Million, 2022
  • Figure 28: RNA Kits Market, $Million, 2022-2033
  • Figure 29: Market Share for RNA Kits Market, $Million, 2022
  • Figure 30: DNA Sample Preparation Kits Market (by Source Type), $Million, 2022 and 2033
  • Figure 31: Cell-Free DNA Sample Preparation Kits Market, $Million, 2022-2033
  • Figure 32: Market Share for Cell-Free DNA Sample Preparation Kits Market, $Million, 2022
  • Figure 33: Cell-Free DNA Sample Preparation Kits Market for Blood, $Million, 2022-2033
  • Figure 34: Cell-Free DNA Sample Preparation Kits Market for Serum/Plasma, $Million, 2022-2033
  • Figure 35: Cell-Free DNA Sample Preparation Kits Market for Other Sources, $Million, 2022-2033
  • Figure 36: Cell-Free DNA Sample Preparation Kits Market for Prenatal and Hereditary Testing, $Million, 2022-2033
  • Figure 37: Cell-Free DNA Sample Preparation Kits Market for Tumor Testing, $Million, 2022-2033
  • Figure 38: Cell-Free DNA Sample Preparation Kits Market for Transplantation, $Million, 2022-2033
  • Figure 39: Genomic DNA Sample Preparation Kits Market, $Million, 2022-2033
  • Figure 40: Market Share for Genomic DNA Sample Preparation Kits Market, $Million, 2022
  • Figure 41: Genomic DNA Sample Preparation Kits Market for Blood, $Million, 2022-2033
  • Figure 42: Market Share for Genomic DNA Sample Preparation Market for Blood, $Million, 2022
  • Figure 43: Genomic DNA Sample Preparation Kits Market for Body Fluids, $Million, 2022-2033
  • Figure 44: Market Share for Genomic DNA Sample Preparation Kits Market for Body Fluids, $Million, (2022)
  • Figure 45: Genomic DNA Sample Preparation Kits Market for Buccal, $Million, 2022-2033
  • Figure 46: Market Share for Genomic DNA Sample Preparation Kits Market for Buccal, $Million, 2022
  • Figure 47: Genomic DNA Sample Preparation Kits Market for Cell/Cultured Cell, $Million, 2022-2033
  • Figure 48: Market Share for Genomic DNA Sample Preparation Kits Market for Cell/Cultured Cell, $Million, 2022
  • Figure 49: Genomic DNA Sample Preparation Kits Market for FFPE, $Million, 2022-2033
  • Figure 50: Market Share for Genomic DNA Sample Preparation Kits Market for FFPE, $Million, 2022
  • Figure 51: Genomic DNA Sample Preparation Kits Market for Forensic, $Million, 2022-2033
  • Figure 52: Market Share for Genomic DNA Sample Preparation Kits Market for Forensic, $Million, 2022
  • Figure 53: Genomic DNA Sample Preparation Kits Market for Plant, $Million, 2022-2033
  • Figure 54: Market Share for Genomic DNA Sample Preparation Kits Market for Plant, $Million, 2022
  • Figure 55: Genomic DNA Sample Preparation Kits Market for Saliva/Swab, $Million, 2022-2033
  • Figure 56: Market Share for Genomic DNA Sample Preparation Kits Market for Saliva/Swab, $Million, 2022
  • Figure 57: Genomic DNA Sample Preparation Kits Market for Serum/Plasma, $Million, 2022-2033
  • Figure 58: Market Share for Genomic DNA Sample Preparation Kits Market for Serum/Plasma, $Million, 2022
  • Figure 59: Genomic DNA Sample Preparation Kits Market for Tissue, $Million, 2022-2033
  • Figure 60: Market Share for Genomic DNA Sample Preparation Kits Market for Tissue, $Million, 2022
  • Figure 61: Genomic DNA Sample Preparation Kits Market for Combined Segment, $Million, 2022-2033
  • Figure 62: Market Share for Genomic DNA Sample Preparation Kits Market for Stool, Urine, and Other Samples, $Million, 2022
  • Figure 63: Microbe DNA Sample Preparation Kits Market, $Million, 2022-2033
  • Figure 64: Market Share for Microbe DNA Sample Preparation Kits Market, $Million, 2022
  • Figure 65: Microbial DNA Sample Preparation Kits Market for Bacterial, $Million, 2022-2033
  • Figure 66: Market Share for Microbial DNA Sample Preparation Kits Market for Bacterial, $Million, 2022
  • Figure 67: Microbial DNA Sample Preparation Kits Market for Fungus, $Million, 2022-2033
  • Figure 68: Market Share for Microbial DNA Sample Preparation Kits Market for Fungus, $Million, 2022
  • Figure 69: Microbial DNA Sample Preparation Kits Market for Yeast, $Million, 2022-2033
  • Figure 70: Market Share for Microbial DNA Sample Preparation Kits Market for Yeast, $Million, 2022
  • Figure 71: Microbial DNA Sample Preparation Kits Market for Other Sources, $Million, 2022-2033
  • Figure 72: Plasmid DNA Sample Preparation Kits Market, $Million, 2022-2033
  • Figure 73: Market Share for Plasmid DNA Sample Preparation Kits Market, $Million, 2022
  • Figure 74: Plasmid GigaPrep Sample Preparation Kits Market, $Million, 2022-2033
  • Figure 75: Market Share for Plasmid GigaPrep Sample Preparation Kits Market, $Million, 2022
  • Figure 76: Plasmid MaxiPrep Sample Preparation Kits Market, $Million, 2022-2033
  • Figure 77: Market Share for Plasmid MaxiPrep Sample Preparation Kits Market, $Million, 2022
  • Figure 78: Plasmid MegaPrep Sample Preparation Kits Market, $Million, 2022-2033
  • Figure 79: Market Share for Plasmid MegaPrep Sample Preparation Kits Market, $Million, 2022
  • Figure 80: Plasmid MidiPrep Sample Preparation Kits Market, $Million, 2022-2033
  • Figure 81: Market Share for Plasmid MidiPrep Sample Preparation Kits Market, $Million, 2022
  • Figure 82: Plasmid MiniPrep Sample Preparation Kits Market, $Million, 2022-2033
  • Figure 83: Market Share for Plasmid MiniPrep Sample Preparation Kits Market, $Million, 2022
  • Figure 84: Viral DNA Sample Preparation Kits Market, $Million, 2022-2033
  • Figure 85: Market Share for Viral DNA Sample Preparation Kits Market, $Million, 2022
  • Figure 86: RNA Sample Preparation Kits Market, $Million, 2022 and 2033
  • Figure 87: Genomic RNA Kits Market, $Million, 2022-2033
  • Figure 88: Genomic RNA Kits Market Share, 2022
  • Figure 89: Genomic RNA Kits for Blood Market, $Million, 2022-2033
  • Figure 90: Genomic RNA Extraction Kits from Blood, Market Share, 2022
  • Figure 91: Body Fluids Genomic RNA Kits Market, $Million, 2022-2033
  • Figure 92: Cell/Cultured Cell Genomic RNA Kits Market, $Million, 2022-2033
  • Figure 93: FFPE Genomic RNA Kits Market, $Million, 2022-2033
  • Figure 94: FFPE Genomic RNA Extraction Kits, Market Share, 2022
  • Figure 95: Plant Genomic RNA Kits Market, $Million, 2022-2033
  • Figure 96: Saliva/Swab Genomic RNA Kits Market, $Million, 2022-2033
  • Figure 97: Serum/Plasma Genomic RNA Kits Market, $Million, 2022-2033
  • Figure 98: Serum/Plasma Genomic RNA Extraction Kits, Market Share, 2022
  • Figure 99: Tissue Genomic RNA Kits Market, $Million, 2022-2033
  • Figure 100: Tissue Genomic RNA Extraction Kits, Market Share, 2022
  • Figure 101: Urine Genomic RNA Kits Market, $Million, 2022-2033
  • Figure 102: Other Genomic RNA Kits Market, $Million, 2022-2033
  • Figure 103: Microbial RNA Kits Market, $Million, 2022-2033
  • Figure 104: Microbial RNA Kits Market Share, 2022
  • Figure 105: Bacterial RNA Kits Market, $Million, 2022-2033
  • Figure 106: Bacterial RNA Kits Market Share, 2022
  • Figure 107: Yeast RNA Kits Market, $Million, 2022-2033
  • Figure 108: Yeast RNA Kits Market Share, 2022
  • Figure 109: Fungus RNA Kits Market, $Million, 2022-2033
  • Figure 110: Fungal RNA Kits Market Share, 2022
  • Figure 111: Other Microbial RNA Kits Market, $Million, 2022-2033
  • Figure 112: Viral RNA Kits Market, $Million, 2022-2033
  • Figure 113: Viral RNA Kits Market Share, 2022
  • Figure 114: Cell-Free RNA Kits Market, $Million, 2022-2033
  • Figure 115: Cell-free RNA Kits Market Share, 2022
  • Figure 116: Serum/Plasma Cell-Free RNA Kits Market, $Million, 2022-2033
  • Figure 117: Other Cell-Free RNA Kits Market, $Million, 2022-2033
  • Figure 118: Nucleic Acid Sample Preparation Consumables Market (by Technology), $Million, 2022 and 2033
  • Figure 119: Silica-Based Consumables Market, $Million, 2022-2033
  • Figure 120: Magnetic Particle-based Consumables Market, $Million, 2022-2033
  • Figure 121: Nucleic Acid Sample Preparation Consumables Market (by Technological Downstream Applications), $Million, 2022 and 2033
  • Figure 122: PCR Market, $Million, 2022-2033
  • Figure 123: qPCR Market, $Million, 2022-2033
  • Figure 124: NGS Market, $Million, 2022-2033
  • Figure 125: Cloning Market, $Million, 2022-2033
  • Figure 126: Microarray Market, $Million, 2022-2033
  • Figure 127: Blotting Techniques Market, $Million, 2022-2033
  • Figure 128: Other Applications Market, $Million, 2022-2033
  • Figure 129: Nucleic Acid Sample Preparation Consumables Market (by End User), $Million, 2022 and 2033
  • Figure 130: Academic Research Institutes and Laboratories Market, $Million, 2022-2033
  • Figure 131: Pharmaceutical and Biotechnology Companies Market, $Million, 2022-2033
  • Figure 132: Contract Research Organizations Market, $Million, 2022-2033
  • Figure 133: Applied Testing Market, $Million, 2022-2033
  • Figure 134: Clinical Diagnostic Center Market, $Million, 2022-2033
  • Figure 135: Nucleic Acid Sample Preparation Consumables Market (by Region), $Million, 2022 and 2033
  • Figure 136: North America Nucleic Acid Sample Preparation Consumables Market, $Million, 2022-2033
  • Figure 137: U.S. Nucleic Acid Sample Preparation Consumables Market, $Million, 2022-2033
  • Figure 138: Canada Nucleic Acid Sample Preparation Consumables Market, $Million, 2022-2033
  • Figure 139: EMEA Nucleic Acid Sample Preparation Consumables Market, $Million, 2022-2033
  • Figure 140: LATAM Nucleic Acid Sample Preparation Consumables Market, $Million, 2022-2033
  • Figure 141: APAC Nucleic Acid Sample Preparation Consumables Market, $Million, 2022-2033
  • Figure 142: China Nucleic Acid Sample Preparation Consumables Market, $Million, 2022-2033
  • Figure 143: Japan Nucleic Acid Sample Preparation Consumables Market, $Million, 2022-2033
  • Figure 144: Rest-of-APAC Nucleic Acid Sample Preparation Consumables Market, $Million, 2022-2033
  • Figure 145: Nucleic Acid Sample Preparation Instrument Market (by Workflow), $Million, 2022 and 2033
  • Figure 146: Isolation/Extraction/Purification Instrument Market, $Million, 2022-2033
  • Figure 147: Quality Control/Quantification Instrument Market, $Million, 2022-2033
  • Figure 148: Nucleic Acid Sample Preparation Instrument Market (by Technology), $Million, 2022 and 2033
  • Figure 149: Automated Spin Column-Based Instrument Market, $Million, 2022-2033
  • Figure 150: Magnetic Bead-based Instrument Market, $Million, 2022-2033
  • Figure 151: Automated Liquid Handling Instruments Market, $Million, 2022-2033
  • Figure 152: Nucleic Acid Extraction/Isolation/Purification Instrument Market (by Throughput), $Million, 2022 and 2033
  • Figure 153: Low Throughput Instrument Market, $Million, 2022-2033
  • Figure 154: Medium Throughput Instrument Market, $Million, 2022-2033
  • Figure 155: High Throughput Instrument Market, $Million, 2022-2033
  • Figure 156: Quality Control/Quantification Instruments, (by Technology), $Million, 2022 and 2033
  • Figure 157: Spectrophotometers Market, $Million, 2022-2033
  • Figure 158: Fluorometers Market, $Million, 2022-2033
  • Figure 159: Others Market, $Million, 2022-2033
  • Figure 160: Nucleic Acid Sample Preparation Instrument Market (by End User), $Million, 2022 and 2033
  • Figure 161: Nucleic Acid Sample Preparation Instrument Market for Academic Research Institutes, $Million, 2022-2033
  • Figure 162: Nucleic Acid Sample Preparation Instrument Market for Pharmaceutical and Biotechnology Companies, $Million, 2022-2033
  • Figure 163: Nucleic Acid Sample Preparation Instrument Market for Clinical Diagnostic Centers, $Million, 2022-2033
  • Figure 164: Nucleic Acid Sample Preparation Instrument Market for Applied Testing, $Million, 2022-2033
  • Figure 165: Nucleic Acid Sample Preparation Instrument Market for Contract Research Organizations, $Million, 2022-2033
  • Figure 166: Nucleic Acid Sample Preparation Instrument Market (by Region), $Million, 2022 and 2033
  • Figure 167: North America Nucleic Acid Sample Preparation Instrument Market, $Million, 2022-2033
  • Figure 168: North America Nucleic Acid Sample Preparation Instrument Market (by Country), $Million, 2022-2033
  • Figure 169: U.S. Nucleic Acid Sample Preparation Instrument Market, $Million, 2022-2033
  • Figure 170: Canada Nucleic Acid Sample Preparation Instrument Market, $Million, 2022-2033
  • Figure 171: EMEA Nucleic Acid Sample Preparation Instrument Market, $Million, 2022-2033
  • Figure 172: APAC Nucleic Acid Sample Preparation Instrument Market, $Million, 2022-2033
  • Figure 173: APAC Nucleic Acid Sample Preparation Instrument Market (by Country) $Million, 2022-2033
  • Figure 174: China Nucleic Acid Sample Preparation Instrument Market, $Million, 2022-2033
  • Figure 175: Japan Nucleic Acid Sample Preparation Instrument Market, $Million, 2022-2033
  • Figure 176: Rest-of-APAC Nucleic Acid Sample Preparation Instrument Market, $Million, 2022-2033
  • Figure 177: LATAM Nucleic Acid Sample Preparation Instrument Market, $Million, 2022-2033
  • Figure 178: Market Share Analysis for the Global Nucleic Acid Sample Preparation (Instrument and Kits) Market, 2022
  • Figure 179: Market Share Analysis for the Global Nucleic Acid Sample Preparation Instrument Market, 2022
  • Figure 180: Agilent Technologies, Inc.: Key Product Portfolio
  • Figure 181: Agilent Technologies, Inc.: Overall Financials, 2020-2022
  • Figure 182: Agilent Technologies, Inc.: R&D Expenditure, 2022-2022
  • Figure 183: AutoGen, Inc.: Key Product Portfolio
  • Figure 184: Bio-Rad Laboratories, Inc.: Key Product Portfolio
  • Figure 185: Bio-Rad Laboratories, Inc.: Overall Financials, 2022-2022
  • Figure 186: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2022-2022
  • Figure 187: F. Hoffmann-La Roche AG: Key Product Portfolio
  • Figure 188: F. Hoffmann-La Roche AG: Overall Financials, 2020-2022
  • Figure 189: F. Hoffmann-La Roche AG: R&D Expenditure, 2020-2022
  • Figure 190: Merck KGaA: Key Product Offerings
  • Figure 191: Merck KGaA: Overall Financials, 2022-2022
  • Figure 192: Merck KGaA: R&D Expenditure, 2022-2022
  • Figure 193: Macherey-Nagel GmbH & Co KG: Key Product Portfolio
  • Figure 194: New England Biolabs, Inc: Key Product Offerings
  • Figure 195: Norgen Biotek Corp.: Key Product Portfolio
  • Figure 196: Omega Bio-tek, Inc.: Key Product Portfolio
  • Figure 197: Revvity, Inc. (PerkinElmer, Inc.): Key Product Portfolio
  • Figure 198: Revvity, Inc. (PerkinElmer, Inc.): Overall Financials, (2022-2022)
  • Figure 199: Revvity, Inc. (PerkinElmer, Inc.): R&D Expenditure, 2022-2022
  • Figure 200: Promega Corporation: Key Product Portfolio
  • Figure 201: QIAGEN N.V.: Key Product Offerings
  • Figure 202: QIAGEN N.V.: Overall Financials, 2022-2022
  • Figure 203: QIAGEN N.V.: R&D Expenditure, 2022-2022
  • Figure 204: Sage Science, Inc.: Key Product Portfolio
  • Figure 205: Tecan Group: Key Product Portfolio
  • Figure 206: Tecan Group: Overall Financials, 2022-2022
  • Figure 207: Tecan Group: R&D Expenditure, 2022-2022
  • Figure 208: Thermo Fisher Scientific Inc.: Key Product Offerings
  • Figure 209: Thermo Fisher Scientific Inc.: Overall Financials, 2022-2022
  • Figure 210: Thermo Fisher Scientific Inc.: R&D Expenditure, 2022-2022
  • Figure 211: Zymo Research: Key Product Portfolio
  • Figure 212: Global Nucleic Acid Sample Preparation Market Methodology
  • Figure 213: Primary Research Methodology
  • Figure 214: Bottom-Up Approach (Segment-Wise Analysis)

List of Tables

  • Table 1: Likert Scale
  • Table 2: Impact Analysis of Market Drivers
  • Table 3: Impact Analysis of Market Restraints
  • Table 4: Commercially Available CTC Isolation Technologies
  • Table 5: Key Market Players Offering Ultra Pure Extraction Kits
  • Table 6: Key Automated DNA Extraction/Isolation/Purification and Quantification/Quality Control Systems Price and Material Cost per Sample
  • Table 7: Pricing of Market Available Consumables
  • Table 8: Other Technologies Consumables Market, $Million, 2022-2033
  • Table 9: Academic Research Institutes and Laboratories Consumables Market (by Analyte), $Million, 2022-2033
  • Table 10: Pharmaceutical and Biotechnology Companies Consumables Market (by Analyte), $Million, 2022-2033
  • Table 11: Contract Research Organizations Consumables Market (by Analyte), $Million, 2022-2033
  • Table 12: Applied Testing Consumables Market, (by Analyte) $Million, 2022-2033
  • Table 13: Clinical Diagnostic Center Consumables Market (by Analyte), $Million, 2022-2033
  • Table 14: Global Nucleic Acid Sample Preparation Consumables Market (by Region), $Million, 2022-2033
  • Table 15: Global DNA Sample Preparation Kits Market (by Region), $Million, 2022-2033
  • Table 16: Global RNA Sample Preparation Kits Market (by Region), $Million, 2022-2033
  • Table 17: Global Nucleic Acid Sample Preparation Reagents Market (by Region), $Million, 2022-2033
  • Table 18: North America Nucleic Acid Sample Preparation Consumables Market (by Analyte), $Million, 2022-2033
  • Table 19: North America DNA Sample Preparation Kits Market (by Source), $Million, 2022-2033
  • Table 20: North America RNA Sample Preparation Kits Market (by Source), $Million, 2022-2033
  • Table 21: EMEA Nucleic Acid Sample Preparation Consumables Market (by Country), $Million, 2022-2033
  • Table 22: EMEA Nucleic Acid Sample Preparation Consumables Market (by Analyte), $Million, 2022-2033
  • Table 23: EMEA DNA Sample Preparation Kits Market (by Source), $Million, 2022-2033
  • Table 24: EMEA RNA Sample Preparation Kits Market (by Source), $Million, 2022-2033
  • Table 25: LATAM Nucleic Acid Sample Preparation Consumables Market (by Country), $Million, 2022-2033
  • Table 26: LATAM Nucleic Acid Sample Preparation Consumables Market (by Analyte), $Million, 2022-2033
  • Table 27: LATAM DNA Sample Preparation Kits Market (by Source), $Million, 2022-2033
  • Table 28: LATAM RNA Sample Preparation Kits Market (by Source), $Million, 2022-2033
  • Table 29: APAC Nucleic Acid Sample Preparation Consumables Market (by Country), $Million, 2022-2033
  • Table 30: APAC Nucleic Acid Sample Preparation Consumables Market (by Analyte), $Million, 2022-2033
  • Table 31: APAC DNA Sample Preparation Kits Market (by Source), $Million, 2022-2033
  • Table 32: APAC RNA Sample Preparation Kits Market (by Source), $Million, 2022-2033
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!